CASE REPORT
Published on 20 Dec 2024
Camrelizumab-Induced Immune-Related Toxic Epidermal Necrolysis in Lung Adenocarcinoma: A Case Report and Literature Review
doi 10.3389/fonc.2024.1417936
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Autophagy and Lung Cancer Therapy: Targeted Drug Development and New Emerging Technology
Autophagy and Lung Cancer Therapy: Targeted Drug Development and New Emerging Technology
1,988
Total Downloads
6,646
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 29 Aug 2024
Lorlatinib in the treatment of a rare pulmonary mucoepidermoid carcinoma with EML4-ALK fusion: a case report and literature review
doi 10.3389/fonc.2024.1415254
- 356 views
ORIGINAL RESEARCH
Published on 05 Jul 2024
Inhibition of NNMT enhances drug sensitivity in lung cancer cells through mediation of autophagy
doi 10.3389/fphar.2024.1415310
- 936 views
REVIEW
Published on 19 Jun 2024
Insights into the role of mitophagy in lung cancer: current evidence and perspectives
doi 10.3389/fphar.2024.1420643
- 794 views
- 1 citation
ORIGINAL RESEARCH
Published on 15 Apr 2024
The cost-effectiveness of iruplinalkib versus alectinib in anaplastic lymphoma kinase-positive crizotinib-resistant advanced non-small-cell lung cancer patients in China
doi 10.3389/fpubh.2024.1333487
- 1,084 views
- 1 citation
SYSTEMATIC REVIEW
Published on 27 Feb 2024
Global research and emerging trends in autophagy in lung cancer: a bibliometric and visualized study from 2013 to 2022
doi 10.3389/fphar.2024.1352422
- 1,612 views
- 4 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Public Health
- 3.0 impact factor
- 4.8 citescore
Impact
- 6,646Topic views
- 3,975Article views
- 1,988Article downloads